Singh Lab continues to focus on enhancing the function of immune cell therapies
Nathan Singh, MD, MS, Associate Professor, WashU Medicine Division of Oncology, has received a continuation grant from the Damon Runyon Cancer Research Foundation. The Foundation’s Continuation Grant program supports Damon Runyon Clinical Investigators who are approaching the end of their original awards and need additional time to work on a promising research avenue or clinical trial.
Support from Damon Runyon comes at a critical time when federal support for research is highly unstable. With this continuation grant we are able to keep working on projects to develop new cell-based therapies for patients who need it the most.
The Singh Lab has continues to focus on enhancing the function of immune cell therapies. Since original funding from Damon Runyon in 2022, we have added new techniques like advanced protein modeling and engineering to better understand what makes engineered cells “tick” and develop techniques to precisely control their activity through synthetic molecular circuits.